gaboxadol has been researched along with 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zharkovskaia, TA; Zharkovskiĭ, AM | 1 |
Babich, M; Branda, EM; Elfline, GS; Quock, RM | 1 |
2 other study(ies) available for gaboxadol and 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one
Article | Year |
---|---|
[Antiabstinent action of fenibut and baclofen on a model of abstinence induced by the benzodiazepine receptor antagonist CGS 8216 in rats receiving diazepam].
Topics: Animals; Baclofen; Behavior, Animal; Diazepam; Drug Evaluation, Preclinical; gamma-Aminobutyric Acid; Isoxazoles; Male; Pyrazoles; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome; Tranquilizing Agents | 1987 |
Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze.
Topics: Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; GABA Agonists; GABA-A Receptor Agonists; Injections, Intraventricular; Isoxazoles; Male; Mice; Nitric Oxide Synthase; Nitroarginine; Pyrazoles; Pyridazines | 2004 |